Skip to main content

EDITORIAL article

Front. Cell Dev. Biol.
Sec. Cell Growth and Division
Volume 12 - 2024 | doi: 10.3389/fcell.2024.1519874
This article is part of the Research Topic Phosphorylation-Dependent Peptidyl-Prolyl Cis/Trans Isomerase PIN1 - Volume II View all 9 articles

Editorial: Exploring the Intricacies of Phosphorylation-Dependent Peptidyl-Prolyl Cis/Trans Isomerase PIN1 - Volume II

Provisionally accepted
  • Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Japan

The final, formatted version of the article will be published soon.

    underlying PIN1-mediated signaling pathways and explores the therapeutic implications of targeting PIN1 in disease intervention.We begin with original research articles that unveil novel insights into PIN1 biology and its implications for disease pathology and treatment. The development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma offers a valuable tool for studying this aggressive malignancy and investigating potential Collectively, the articles in this volume contribute to our growing understanding of the intricate roles of PIN1 in cellular physiology and pathology. As we navigate through the complexities of PIN1 biology, it becomes increasingly clear that a multidisciplinary approach is essential to fully comprehend its diverse roles in health and disease. By integrating knowledge from fields such as biochemistry, structural biology, cell biology, and medicine, we can gain a more comprehensive understanding of PIN1 function and its implications for human health. We extend our sincere appreciation to the authors for their outstanding contributions and to the readers for their interest in this topic. Together, let us continue to unravel the complexities of phosphorylation-dependent peptidyl-prolyl cis/trans isomerase PIN1 and explore its therapeutic potential for improving human health and well-being.Keywords: PIN1, phosphorylation, peptidyl-prolyl isomerization, PIN1 inhibitor, cancer, Alzheimer's disease, viral infection, tau, dementia Futoshi SuizuEditorial Team

    Keywords: Pin1, Phosphorylation, Peptidyl-prolyl cis- trans isomerase, Cancer, viral infection, Dementia, Alzheimer disease

    Received: 30 Oct 2024; Accepted: 30 Oct 2024.

    Copyright: © 2024 Suizu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Futoshi Suizu, Department of Medical Technology, Kagawa Prefectural University of Health Sciences, Takamatsu, Japan

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.